Middle East Pharmaceutical Industries Company Overview
Pro stress-test →Avalon Pharma develops, manufactures, markets, and distributes a range of pharmaceutical and generic medicines in Saudi Arabia and abroad through a diverse, high-quality product portfolio covering several therapeutic categories. The company produces more than 250 products, falling under more than 70 brands. Recently listed on Tadawul (February 27, 2024), Avalon represents a significant entrant in the Saudi pharmaceutical sector with established manufacturing capabilities and geographic expansion.
Strategic Profile
Pro stress-test →The company operates three factories in Riyadh equipped with production and manufacturing lines for creams, cosmetics, liquid and solid medicines, and disinfectants. Avalon Pharma has a wholly owned subsidiary in the UK, Avalon Pharma UK Holdings Limited, which owns three subsidiaries, demonstrating international growth ambitions. The company leverages vertical integration across manufacturing and distribution to address regional healthcare needs in underserved therapeutic categories.
Competitive Landscape
Pro stress-test →Avalon Pharma competes in Saudi Arabia's pharma, biotech and life sciences sector alongside peers including Jamjoom Pharma (4015), SPIMACO (2070), and regional healthcare providers such as Mouwasat, Dallah Health, and Saudi German Health. As a generic medicine and OTC-focused player with manufacturing scale, Avalon differentiates through in-house production efficiency and regional distribution networks versus import-dependent competitors. Market consolidation and Vision 2030 localization initiatives favor integrated manufacturers.
Industry Context
Middle East Pharmaceutical Industries Company operates in Pharmaceutical Manufacturing & Generic Medicines.
Key facts
Founded: 1998 · Headquarters: Riyadh, Saudi Arabia · Employees: 501-1000 · Market cap: $438M